Daewoong Chemical Takes Over Manufacturing Plant with Finished Product Capability

Published: 2005-03-08 06:56:00

Updated: 2005-03-08 06:56:00

Daewoong Chemical announced last week of its pharmaceutical business extension into the finished product category, by assuming an ownership of Lilly Korea's manufacturing plant with injection, capsule and dry syrup preparation capabilities.

Daewoong Chemical is specialized in the production of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK